First-year results of the International Leukemia/Lymphoma Target Board for pediatric relapsed and refractory hematological malignancies
Year: 2026
Type: article
Abstract: Not available.
Source: Haematologica
Authors: Uri Ilan, Judith M. Boer, Maaike Luesink, Francisco Bautista, Mattias Hofmans, Aditi Vedi, Bálint Egyed, Birgit Geoerger, Ruta Tuckuviene, Bodil Als-Nielsen, Pablo Velasco, Jose Luis Fuster, Alba Rubio, Sarah K. Tasian, Frederik van Delft, Julie A.E. Irving, Dániel J. Erdély, Kjeld Schmiegelow, Barbara De Moerloose, André Baruchel, Monique L. Den Boer, Michel C. Zwaan
Institutions: Princess Máxima Center, Ghent University Hospital, Cambridge University Hospitals NHS Foundation Trust, Semmelweis University, Inserm, Université Paris-Saclay, Aalborg University Hospital, Rigshospitalet, Vall d'Hebron Hospital Universitari, Hospital Universitario Virgen de la Arrixaca, Hospital Infantil Universitario Niño Jesús, Children's Hospital of Philadelphia, University of Pennsylvania, Newcastle University, Université Paris Cité, Hôpital Robert-Debré, Utrecht University, University Medical Center Utrecht, Erasmus MC - Sophia Children’s Hospital
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,157
Awards: Towards rational design of combination therapeutic targets, Multispecific targeting incorporating cytokine receptor pathways in high risk pediatric acute leukemias to improve durability of adoptive cell therapy-induced remissions, Identifying Relapse Predictors and Therapeutic Vulnerabilities in Ph+ and Ph-like Acute Lymphoblastic Leukemia
OpenAlex ID: W7148581760
FWCI:
Cites:
Cited by:
Related to: